# Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease

> **NCT02875041** · NA · WITHDRAWN · sponsor: **NYU Langone Health**

## Conditions studied

- Parkinson's Disease

## Interventions

- **DEVICE:** Transcranial Magnetic Stimulation (TMS)
- **DEVICE:** MAGSTIM Rapid2

## Key facts

- **NCT ID:** NCT02875041
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08
- **Primary completion:** 2018-05-02
- **Final completion:** 2018-05-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study required back-to-back physical therapy (PT) and TMS Experimental sessions; as our practice move to another building, away from PT
- **Last updated:** 2019-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02875041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02875041, "Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02875041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*